Shares of C.R. Bard Inc. (NYSE:BCR) dropped 4.1% during trading on Wednesday . The company traded as low as $221.01 and last traded at $221.95, with a volume of 500,441 shares changing hands. The stock had previously closed at $231.47.

BCR has been the subject of a number of research reports. Bank of America Corp. cut C.R. Bard from a “buy” rating to a “neutral” rating in a research report on Friday, July 8th. Zacks Investment Research cut C.R. Bard from a “buy” rating to a “hold” rating in a research report on Tuesday, April 12th. Barclays PLC upped their price objective on C.R. Bard from $212.00 to $224.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 24th. Leerink Swann upped their price objective on C.R. Bard from $196.00 to $205.00 and gave the company a “market perform” rating in a research report on Wednesday, March 30th. Finally, Piper Jaffray Cos. reiterated a “buy” rating and set a $241.00 price objective on shares of C.R. Bard in a research report on Tuesday, May 24th. Thirteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. C.R. Bard presently has a consensus rating of “Hold” and an average target price of $229.92.

The stock has a market capitalization of $16.40 billion and a P/E ratio of 151.22. The company’s 50-day moving average price is $230.52 and its 200 day moving average price is $207.96.

C.R. Bard (NYSE:BCR) last issued its quarterly earnings results on Tuesday, July 26th. The company reported $2.54 EPS for the quarter, topping the Zacks’ consensus estimate of $2.47 by $0.07. The firm had revenue of $931.50 million for the quarter, compared to analyst estimates of $915.22 million. The business’s revenue was up 8.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.27 EPS. On average, equities research analysts anticipate that C.R. Bard Inc. will post $10.15 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Monday, July 18th will be paid a dividend of $0.26 per share. This is a positive change from C.R. Bard’s previous quarterly dividend of $0.24. The ex-dividend date is Thursday, July 14th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.47%.

In other C.R. Bard news, insider Jim C. Beasley sold 4,709 shares of C.R. Bard stock in a transaction dated Thursday, April 28th. The stock was sold at an average price of $215.00, for a total transaction of $1,012,435.00. Following the completion of the transaction, the insider now owns 27,378 shares in the company, valued at approximately $5,886,270. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Christopher S. Holland sold 3,970 shares of C.R. Bard stock in a transaction dated Friday, May 27th. The shares were sold at an average price of $219.89, for a total value of $872,963.30. Following the transaction, the chief financial officer now owns 31,306 shares of the company’s stock, valued at approximately $6,883,876.34. The disclosure for this sale can be found here.

Other institutional investors recently added to or reduced their stakes in the company. Marshall Wace LLP raised its position in C.R. Bard by 155.1% in the fourth quarter. Marshall Wace LLP now owns 375,232 shares of the company’s stock worth $71,084,000 after buying an additional 228,166 shares during the last quarter. Bank of Montreal Can raised its position in C.R. Bard by 58.3% in the fourth quarter. Bank of Montreal Can now owns 166,831 shares of the company’s stock worth $31,604,000 after buying an additional 61,469 shares during the last quarter. BlackRock Advisors LLC raised its position in C.R. Bard by 6.4% in the fourth quarter. BlackRock Advisors LLC now owns 306,584 shares of the company’s stock worth $58,079,000 after buying an additional 18,361 shares during the last quarter. Airain ltd bought a new position in C.R. Bard during the fourth quarter worth $2,587,000. Finally, Cornerstone Capital Management Holdings LLC. raised its position in C.R. Bard by 9.9% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 124,777 shares of the company’s stock worth $23,638,000 after buying an additional 11,204 shares during the last quarter.

C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.